Back

Impact of metabolic syndrome on the risk of ischemic stroke in non-anticoagulated atrial fibrillation patients having low CHA2DS2-VASc scores

26 August 2022 (08:00 - 19:30)
Organised by:
Congress Presentation Part of: Clinical challenges in atrial fibrillation Stroke in Atrial Fibrillation ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Hyojeong Ahn

Seoul National University Hospital, Seoul (Korea (Republic of))

5 More presentations in this session

Presentation thumbnail
Perioperative atrial fibrillation in major emergency abdominal surgery: does it affect postoperative outcome?
Miss A. Tas (Copenhagen, DK)
Abstract Slides Video
Presentation thumbnail
Temporal trends and patterns in atrial fibrillation incidence: a population-based study of 3.4 million individuals
Mr K. Raveendra (Leeds, GB)
Abstract Slides Video
Presentation thumbnail
Searching for underlying atrial fibrillation using artificial intelligence-assisted MRI images from ischemic stroke patients
Doctor Z. Zhang (Shanghai, CN)
Abstract Slides
Presentation thumbnail
Comparison of embolism and bleeding risk profile in patients with atrial fibrillation and chronic kidney disease
Mr J. Parada Barcia (Vigo, ES)
Abstract Slides Video
Presentation thumbnail
Watchman device migration and embolization: a report from the NCDR LAAO registry
Doctor D. Friedman (Durham, US)
Abstract Slides Video

Access the full session

Session thumbnail
Clinical challenges in atrial fibrillation

The Event

Event poster

ESC Congress 2022

26 August - 29 August 2022
You may be interested in
thumbnail
Congress Presentation
Association between genetic predisposition of AF and the risk of ischemic stroke and thromboembolism
thumbnail
Congress Presentation
Incidence, management and outcomes of patients with incident atrial fibrillation in the contemporary direct oral anti coagulants era. A national study
thumbnail
Congress Presentation
Evolving trends in stroke prevention with focus on atrial fibrillation: ethnic and sex differences

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources